Advertisement

Topics

"Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors" Drugs and Medication Database

12:52 EST 21st February 2019 | BioPortfolio

Here are the most relevant "Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors" Drugs and Medications that we have found in our database.

More Information about "Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors" on BioPortfolio

We have published hundreds of Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors news stories on BioPortfolio along with dozens of Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors Clinical Trials and PubMed Articles about Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors Companies in our database. You can also find out about relevant Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors Drugs and Medications on this site too.

Showing "Monoclonal Antibody Therapy Treating Patients With Advanced Solid" Drugs and Medications 1–25 of 115

Possibly Relevant

Zinplava [merck sharp & dohme corp.]

These highlights do not include all the information needed to use ZINPLAVA safely and effectively. See full prescribing information for ZINPLAVA. ZINPLAVA™ (bezlotoxumab) injection, for intravenous use Initial U.S. Approval: 2016

Campath [genzyme corporation]

These highlights do not include all the information needed to use CAMPATH safely and effectively. See full prescribing information for CAMPATH. CAMPATH (alemtuzumab) Injection for intravenous useInitial U.S. Approval: 2001

Aimovig [amgen inc]

These highlights do not include all the information needed to use AIMOVIG safely and effectively. See full prescribing information for AIMOVIG. AIMOVIG (erenumab-aooe) injection, for subcutaneous use Initial U.S. Approval: 2018

Ajovy [teva pharmaceuticals usa, inc.]

These highlights do not include all the information needed to use AJOVY safely and effectively. See full prescribing information for AJOVY.AJOVY (fremanezumab-vfrm) injection, for subcutaneous useInitial U.S. Approval: 2018

Emgality [eli lilly and company]

These highlights do not include all the information needed to use EMGALITY safely and effectively. See full prescribing information for EMGALITY.EMGALITY (galcanezumab-gnlm) injection, for subcutaneous useInitial U.S. Approval: 2018

Fasenra [astrazeneca pharmaceuticals lp]

These highlights do not include all the information needed to use FASENRA safely and effectively. See full prescribing information for FASENRA.FASENRA (benralizumab) injection, for subcutaneous useInitial U.S. Approval: 2017

Yervoy [e.r. squibb & sons, l.l.c.]

These highlights do not include all the information needed to use YERVOY safely and effectively. See full prescribing information for YERVOY. YERVOY (ipilimumab) injection, for intravenous useInitial U.S. Approval: 2011

Sylvant [janssen biotech, inc.]

These highlights do not include all the information needed to use SYLVANT safely and effectively. See full prescribing information for SYLVANT. SYLVANT (siltuximab) for injection, for intravenous use Initial U.S. Approval: 2014

Repatha [amgen usa inc.]

These highlights do not include all the information needed to use REPATHA safely and effectively. See full prescribing information for REPATHA .     REPATHA (evolocumab) injection, for subcutaneous use Initial U.S. Approval: 2015

Repatha [amgen inc]

These highlights do not include all the information needed to use REPATHA safely and effectively. See full prescribing information for REPATHA .     REPATHA (evolocumab) injection, for subcutaneous use Initial U.S. Approval: 2015

Praxbind [boehringer ingelheim pharmaceuticals, inc.]

These highlights do not include all the information needed to use PRAXBIND safely and effectively. See full prescribing information for PRAXBIND. PRAXBIND (idarucizumab) injection, for intravenous useInitial U.S. Approval: 2015

Libtayo [regeneron pharmaceuticals, inc.]

These highlights do not include all the information needed to use LIBTAYO safely and effectively. See full prescribing information for LIBTAYO. LIBTAYO (cemiplimab-rwlc) injection, for intravenous useInitial U.S. Approval: 09/2018

Takhzyro [dyax corp.]

These highlights do not include all the information needed to use TAKHZYRO™ safely and effectively. See full prescribing information for TAKHZYRO™. TAKHZYRO™ (lanadelumab-flyo) injection, for subcutaneous use.Initial U.S. Approval: 2018.

Trogarzo [theratechnologies inc.]

These highlights do not include all the information needed to use TROGARZO safely and effectively. See full prescribing information for TROGARZO. TROGARZO™ (ibalizumab-uiyk) injection, for intravenous use Initial U.S. Approval: [2018]

Synagis [medimmune, llc]

These highlights do not include all the information needed to use SYNAGIS safely and effectively. See full prescribing information for SYNAGIS. SYNAGIS (palivizumab) injection, for intramuscular useInitial U.S. Approval: 1998

Lartruvo [eli lilly and company]

These highlights do not include all the information needed to use LARTRUVO safely and effectively. See full prescribing information for LARTRUVO.LARTRUVO (olaratumab) injection, for intravenous useInitial U.S. Approval: 2016

Cyclosporine [mayne pharma inc.]

Cyclosporine Capsules, USP [MODIFIED] (Soft Gelatin) Cyclosporine ORAL SOLUTION, USP [MODIFIED]

Gengraf [abbvie inc.]

GENGRAF Capsules (cyclosporine capsules, USP [MODIFIED])

Gengraf [abbvie inc.]

GENGRAF ORAL SOLUTION(cyclosporine oral solution, USP [MODIFIED])

Oxygen [advanced home care]

Oxygen, USP

Oxygen [advanced health services, inc. ]

Oxygen

Oxygen [carefirst of fort wayne, inc. dba advanced healthcare]

Oxygen

Prostascint kit for the preparation of indium in 111 capromab pendetide [jazz pharmaceuticals, inc.]

ProstaScintKit (capromab pendetide) Kit for the Preparation of Indium In 111 Capromab Pendetide For Intravenous Use Only

Siliq [valeant pharmaceuticals north america llc]

These highlights do not include all the information needed to use SILIQ safely and effectively. See full prescribing information for SILIQ. SILIQ™ (brodalumab) injection, for subcutaneous useInitial U.S. Approval: 2017

One touch advanced topical anesthetic [hager worldwide, inc.]

NA



Advertisement
Quick Search
Advertisement
Advertisement